PRKDC is a prognostic marker for poor survival in gastric cancer patients and regulates DNA damage response

Pathol Res Pract. 2019 Aug;215(8):152509. doi: 10.1016/j.prp.2019.152509. Epub 2019 Jun 20.

Abstract

A hallmark of gastric cancer is the high rate of genomic instability associated with deregulation of DNA damage repair pathways. DNA-Dependent Protein Kinase Catalytic Subunit (PRKDC) is a key component of the non-homologous end-joining (NHEJ) pathway. By reanalyzing transcriptome data of 80 pairs of gastric cancer tumors and the adjacent normal tissues from non-treated patients, we identified PRKDC as the top upregulated DNA damage repair genes in gastric cancer. High expression of PRKDC is associated with poor survival of gastric cancer patients, and genomic amplification of the gene is frequently observed across most gastric cancer subtypes. Knockdown of PRKDC in gastric cell lines resulted in reduced proliferation and cell cycle arrest. Furthermore, we showed that loss of PRKDC induced DNA damage and enhanced gastric cancer cell chemosensitivity to DNA-damaging reagents. Together, our results suggest that PRKDC is a prognostic marker of poor survival and is a putative target to overcome chemoresistance in gastric cancer.

Keywords: Chemoresistance; DNA damage repair; Gastric cancer; PRKDC.

MeSH terms

  • Apoptosis
  • DNA Damage / genetics
  • DNA-Activated Protein Kinase / genetics*
  • DNA-Binding Proteins / metabolism
  • Humans
  • Prognosis
  • Stomach Neoplasms / diagnosis
  • Stomach Neoplasms / genetics*
  • Stomach Neoplasms / pathology*

Substances

  • DNA-Binding Proteins
  • DNA-Activated Protein Kinase
  • PRKDC protein, human